Clinical Trial Update: Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether celecoxib exhibits whole-blood bactericidal activity against tuberculosis in healthy volunteers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED